[1] |
World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
|
[2] |
Al-Rifai RH, Pearson F, Critchley JA, et al. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS One, 2017, 12(11):e0187967. doi:10.1371/journal.pone.0187967.
|
[3] |
Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 2022, 183:109119. doi:10.1016/j.diabres.2021.109119.
|
[4] |
Noubiap JJ, Nansseu JR, Nyaga UF, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2.3 million patients with tuberculosis. Lancet Global Health, 2019, 7(4):e448-e460. doi:10.1016/S2214-109X(18)30487-X.
|
[5] |
Meng F, Lan L, Wu G, et al. Impact of diabetes itself and glycemic control status on tuberculosis. Front Endocrinol (Lausanne), 2023, 14:1250001. doi:10.3389/fendo.2023.1250001.
|
[6] |
Ssekamatte P, Sande OJ, van Crevel R, et al. Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility. Front Immunol, 2023, 14:1122255. doi:10.3389/fimmu.2023.1122255.
|
[7] |
Restrepo BI, Schlesinger LS. Impact of diabetes on the natural history of tuberculosis. Diabetes Res Clin Pract, 2014, 106(2):191-199. doi:10.1016/j.diabres.2014.06.011.
|
[8] |
Harries AD, Kumar AM, Satyanarayana S, et al. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop Med Hyg, 2016, 110: 173-179. doi:10.1093/trstmh/trv111.
|
[9] |
Harries AD, Lin Y, Satyanarayanas S, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis, 2011, 15: 1436-1444, i. doi:10.5588/ijtld.11.0503.
pmid: 21902876
|
[10] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09.
|
[11] |
纪立农, 陈莉明, 郭晓慧, 等. 中国慢性疾病防治基层医生诊疗手册(糖尿病分册)2015年版. 中国糖尿病杂志, 2015, 23(8): 673-701. doi:10.3969/j.issn.1006-6187.2015.08.001.
|
[12] |
World Health Organization. Treatment of Tuberculosis Guideline for National Program. 4th ed. Geneva: World Health Organization, 2009.
|
[13] |
World Health Organization. Guidelines for the treatment of drug-susceptible tuberculosis and patient care, 2017 update. Geneva: World Health Organization, 2017.
|
[14] |
中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南. 北京: 人民卫生出版社, 2021: 249-250.
|
[15] |
Lin Y, Harries AD, Kumar AM, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice. Paris: International Union Against Tuberculosis and Lung Disease, 2019. https://theunion.org/sites/default/files/2020-11/TheUnion_DMTB_Guide.pdf.
|
[16] |
Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health, 2012, 17(10): 1294-1231. doi:10.1111/j.1365-3156.2012.03068.x.
pmid: 22830945
|
[17] |
Lin Y, Li L, Mi F, et al. Screening of patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012, 17(10): 1302-1308. doi:10.1111/j.1365-3156.2012.03069.x.
|
[18] |
van Crevel R, Critchley JA. The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice. Trop Med Infect Dis, 2021, 6(1):8. doi:10.3390/tropicalmed6010008.
|
[19] |
Adepoju VA, Adepoju OE, Inegbeboh J, et al. Bidirectional Screening for Tuberculosis, Diabetes Mellitus and other Comorbid Conditions in a Resource Constrained Setting: A Pilot Study in Lagos, Nigeria. West Afr J Med, 2022, 39(12):1305-1311.
pmid: 36583949
|
[20] |
Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ, 2020, 369:m997. doi:10.1136/bmj.m997.
|
[21] |
Burke RM, Nliwasa M, Feasey HRA, et al. Community-based active case-finding interventions for tuberculosis: a systematic review. Lancet Public Health, 2021, 6(5):e283-e299. doi:10.1016/S2468-2667(21)00033-5.
|
[22] |
van Crevel R, Koesoemadinata R, Hill PC, et al. Clinical management of combined tuberculosis and diabetes. Int J Tuberc Lung Dis, 2018, 22(12):1404-1410. doi:10.5588/ijtld.18.0340.
pmid: 30606312
|
[23] |
Wang JY, Lee MC, Shu CC, et al. Optimal duration of anti-TB treatment in patients with diabetes: nine or six months?. Chest, 2015, 147(2):520-528. doi:10.1378/chest.14-0918.
|